NVEC · NVE Corporation

Current Thesis

NVE Corporation’s surviving thesis is that June’s jump in sensor and coupler sales can support a renewed valuation increase; the next quarterly report must repeat that demand, while a weekly close below $86 ends the recovery case. The 2026-07-22 results reported revenue of $11,034,057, up 81% year over year, and diluted earnings per share of $1.32 versus $0.74. One quarter is too small a sample to establish durable demand. NVE earnings release

The September update leaves the price structure unresolved: the adjusted reference close was $100.51 on 2026-09-11, below the $105 shelf identified in the August coverage. As an interpretation of that failed shelf, the narrative is dead — the break documented on 2026-08-28 remains unrepaired at the latest close. This describes the July price narrative; it does not establish that customer demand has failed.

The disclosure gap concerns operating confirmation. NVE’s 2026-08-10 Form 8-K documented Peter G. Eames becoming president and chief executive officer and Daniel A. Baker becoming chairman, effective 2026-08-06. That filing contradicts the earlier blanket assertion that no filings followed July’s earnings, but supplies no subsequent quarterly sales result. NVE Form 8-K

Bullish and bearish views on NVE Corporation

The model's bull view on NVE Corporation (NVEC), in brief: Product sales drove the increase. Product revenue reached $10,734,735 in the quarter ended 2026-06-30, with contract research and development revenue of $299,322, according to the 2026-07-22 quarterly report. Repeating the product-sales level is the central operating test; a… The bear view: The price recovery remains unconfirmed. On 2026-09-11, the adjusted reference series showed a three-month price decline of 13.3% and a close 24.5% below its $133.06 trailing-year high. Those observations do not identify the cause of the decline. Expenses increased alongside… Both cases follow in full.

Bull Case

• Product sales drove the increase. Product revenue reached $10,734,735 in the quarter ended 2026-06-30, with contract research and development revenue of $299,322, according to the 2026-07-22 quarterly report. Repeating the product-sales level is the central operating test; a lower result would leave that test unmet.
• Margins supported the earnings jump. Gross margin was 81.3% and operating margin was 66% for the June quarter, according to the 2026-07-22 report and earnings call. These are measured quarterly results, not established margins for subsequent quarters.
• Liquid assets provide financial capacity. The 2026-06-30 balance sheet reported cash and equivalents of $2,896,148 and marketable securities of $43,124,354. Those assets support the financial-capacity argument but provide no evidence that June’s orders will recur.

Bear Case

• The price recovery remains unconfirmed. On 2026-09-11, the adjusted reference series showed a three-month price decline of 13.3% and a close 24.5% below its $133.06 trailing-year high. Those observations do not identify the cause of the decline.
• Expenses increased alongside demand. Operating expenses rose 50% year over year in the quarter reported on 2026-07-22, attributed to research staffing and performance compensation. Revenue below June’s level together with operating margin below June’s 66% would confirm weaker operating leverage.
• Insider sales accompanied the advance. Baker’s Forms 4 reported sales of 20,000 common shares during 2026-07-27 through 2026-07-29 and another 1,500 shares on 2026-08-17. These are observable insider transactions; they do not establish his demand outlook.

Setup & Price Structure

The 2026-09-11 adjusted close of $100.51 remained below the previously identified $105 shelf. The 14-period relative strength index (RSI) was 30.8 in the same reference dataset. Neither that reading nor the supplied price snapshots establish a completed base; moving-average levels and a volume history are missing.

The supplied Benzinga coverage clustered around the 2026-07-22 earnings release and 2026-07-23 mover reports. That dates an attention burst, but article clustering is not a measurement of retail ownership or current crowding. No short-interest or fund-flow series is available here, so a squeeze or renewed participation cannot be established.

Catalyst Calendar (next 30 days)

• 2026-09-30 — Fiscal quarter ends. NVE’s financial calendar places its September quarter-end on this date. It closes the operating period under examination; it is not an announced results-release date. NVE investor FAQ
• 2026-09-13 through 2026-10-13 — No confirmed investor event listed. NVE’s investor-events page, checked on 2026-09-13, lists the 2026-08-06 annual meeting as its latest event and provides no forthcoming earnings date. NVE investor events
• ~2026-10-21, estimated — Second-quarter fiscal 2027 results. This remains an unconfirmed estimate outside the next thirty days. The company describes a customary third- or fourth-Wednesday quarterly reporting schedule; its eventual announcement supersedes this estimate. Product sales would test whether the $10,734,735 June-quarter result repeats. NVE reporting schedule

What Would Change Our Mind

Loss of the pre-earnings zone identified in the 2026-08-30 coverage would end the remaining recovery thesis: a weekly close below $86 is the published price condition, evaluated using the adjusted daily-price series. This is a research threshold, not a claim that the latest close has breached it.

For a gradeable recovery outcome, the next quarterly report must show product sales at or above the June quarter’s $10,734,735, accompanied by a weekly close above the previously identified $105 shelf before the $86 condition fires. Product sales below that benchmark would fail the operating confirmation test. A price recovery alone would leave repeat demand unproven.

Correlation Notes

The 2026-07-22 earnings release attributed growth to new products and a strong semiconductor market; that explanation belongs to management. No paired sector-return series is available to distinguish a semiconductor-cycle effect from company-specific demand. This remains a single-name earnings setup, and the evidence does not establish an artificial-intelligence, robotics or small-cap rotation driver. NVE earnings release